| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 349 | 2015 |
| The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 323 | 2016 |
| PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ... Human molecular genetics 23 (15), 4077-4085, 2014 | 242 | 2014 |
| Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function P Pingitore, C Pirazzi, RM Mancina, BM Motta, C Indiveri, A Pujia, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2014 | 139 | 2014 |
| Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease L Valenti, DW Swinkels, L Burdick, P Dongiovanni, H Tjalsma, BM Motta, ... Nutrition, Metabolism and Cardiovascular Diseases 21 (8), 568-575, 2011 | 93 | 2011 |
| Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations L Valenti, P Dongiovanni, BM Motta, DW Swinkels, P Bonara, R Rametta, ... Arteriosclerosis, thrombosis, and vascular biology 31 (3), 683-690, 2011 | 89 | 2011 |
| PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis P Pingitore, P Dongiovanni, BM Motta, M Meroni, SM Lepore, ... Human molecular genetics 25 (23), 5212-5222, 2016 | 84 | 2016 |
| The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage B Donati, BM Motta, P Pingitore, M Meroni, A Pietrelli, A Alisi, S Petta, ... Hepatology 63 (3), 787-798, 2016 | 84 | 2016 |
| Patatin‐like phospholipase domain‐containing 3 I148M affects liver steatosis in patients with chronic hepatitis B M Viganò, L Valenti, P Lampertico, F Facchetti, BM Motta, R D'Ambrosio, ... Hepatology 58 (4), 1245-1252, 2013 | 66 | 2013 |
| The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls L Valenti, R Rametta, M Ruscica, P Dongiovanni, L Steffani, BM Motta, ... BMC gastroenterology 12 (1), 1-11, 2012 | 58 | 2012 |
| Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing C Maglio, RM Mancina, BM Motta, M Stef, C Pirazzi, L Palacios, ... Journal of internal medicine 276 (4), 396-403, 2014 | 56 | 2014 |
| LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease L Valenti, BM Motta, A Alisi, R Sartorelli, G Buonaiuto, P Dongiovanni, ... Journal of pediatric gastroenterology and nutrition 54 (5), 588-593, 2012 | 54 | 2012 |
| PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma L Valenti, BM Motta, G Soardo, M Iavarone, B Donati, A Sangiovanni, ... PloS one 8 (10), e75982, 2013 | 50 | 2013 |
| The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease L Valenti, R Rametta, P Dongiovanni, BM Motta, E Canavesi, S Pelusi, ... PLoS One 7 (11), e48804, 2012 | 46 | 2012 |
| Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin L Valenti, A Aghemo, AF Stättermayer, P Maggioni, S De Nicola, BM Motta, ... Alimentary pharmacology & therapeutics 35 (12), 1434-1442, 2012 | 42 | 2012 |
| The androgen receptor confers protection against diet‐induced atherosclerosis, obesity, and dyslipidemia in female mice JB Fagman, AS Wilhelmson, BM Motta, C Pirazzi, C Alexanderson, ... The FASEB Journal 29 (4), 1540-1550, 2015 | 37 | 2015 |
| Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects R Rametta, E Mozzi, P Dongiovanni, BM Motta, M Milano, G Roviaro, ... International journal of obesity 37 (7), 986-992, 2013 | 36 | 2013 |
| DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection MA Burza, BM Motta, RM Mancina, P Pingitore, C Pirazzi, SM Lepore, ... Hepatology 63 (2), 418-427, 2016 | 28 | 2016 |
| The impact of CRISPR/Cas9 technology on cardiac research: from disease modelling to therapeutic approaches BM Motta, PP Pramstaller, AA Hicks, A Rossini Stem cells international 2017, 2017 | 19 | 2017 |
| HDAC inhibition improves the sarcoendoplasmic reticulum Ca2+-ATPase activity in cardiac myocytes V Meraviglia, L Bocchi, R Sacchetto, MC Florio, BM Motta, C Corti, ... International journal of molecular sciences 19 (2), 419, 2018 | 16 | 2018 |
